Heart failure and renal outcomes in patient treated with GLP1 agonists.

30 August 2024 (09:09 - 09:27)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Nicolas del-Cuerpo-Salinas

UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on biomarkers to guide the treatment of heart failure: where are we going?

Professor J. Januzzi (Boston, US)

Presentation thumbnail

Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials

Doctor T. Kondo (Nagoya, JP)

Abstract Slides Video

Presentation thumbnail

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

Doctor Y. Yu (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Liver function tests in patients receiving high-intensity care after hospital admission for acute heart failure: the STRONG-HF trial

Doctor P. Myhre (Oslo, NO)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers to guide the treatment of heart failure: where are we going?

The Event

Event poster

ESC Congress 2024

30 August 2024 09:09 CET

You may be interested in

Congress Presentation

GLP-1 receptor agonists in cardiorenal disease

Congress Presentation

Cardiovascular outcomes in diabetic patients treated with SGLT2i and GLP1-RA: systematic review and meta-analysis

Congress Presentation

Effects of oral semaglutide on heart failure outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease participating in SOUL trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources